Intermittent Fasting for Women: What the Evidence Actually Shows

Published 7 September 2026

Fasting is a schedule, not a metabolism hack. Every controlled trial that has held total calories constant between a fasting group and a normal-eating group has found roughly the same weight outcome in both. That single fact should shape how you read everything else on this page.

The Three Protocols People Actually Mean

The research groups the popular plans into three families.

• Time-restricted eating. All food inside a fixed daily window, every day. 16:8 means a 16-hour overnight fast and an 8-hour eating window; the TREAT trial tested exactly this, with participants eating from noon to 8pm. 14:10 is the same idea with a wider window, and is easier to hold to.
• The 5:2 diet. Normal eating on five days, heavily restricted intake on two.
• Alternate day fasting. A fast or near-fast day between each normal day. This is the most demanding of the three and, as it turns out, the one with the best trial numbers.

None of these prescribe what you eat. That is the whole point of the argument below.

Intermittent Fasting for Women

A 2025 network meta-analysis in the BMJ pooled 99 randomised trials covering 6,582 adults. Every fasting strategy beat eating without restriction. Against continuous energy restriction, which is ordinary calorie counting, only alternate day fasting won, by 1.29 kg (95% CI 1.99 to 0.59 kg), rated moderate certainty. In the 17 trials that ran 24 weeks or longer, no fasting strategy beat calorie counting at all.

An earlier meta-analysis of 24 trials in 1,768 people found the same thing more bluntly: fasting versus calorie restriction came out at a 0.26 kg mean difference, which was not statistically significant.

For women specifically, a 2026 systematic review pooled 22 randomised trials in 1,287 women with overweight or obesity. Fasting reduced body mass index by 0.41 points and fasting blood glucose by 2.18 mg/dL, with no significant effect on blood pressure. The authors flag substantial heterogeneity between studies and describe the certainty as limited. That is a real effect, and it is a small one.

The clearest single result is the NEJM trial that put 139 adults with obesity on the same calorie target for 12 months, 1,200 to 1,500 kcal a day for women, and gave one group an 8am to 4pm eating window. Twelve months later the window group had lost 8.0 kg and the calorie-only group 6.3 kg, a difference of 1.8 kg that did not reach statistical significance.

Fasting is a way to create a calorie deficit. It works when it makes you eat less and it stops working when it does not. If you have never put a number on what you are eating now, work out your TDEE first and then read how much a woman should actually eat to lose weight. A window with no deficit behind it changes nothing.

The Claim That Women Must Fast Differently

This is the most repeated advice in the category and the weakest supported. The specific fear is that fasting disrupts female sex hormones.

The best test of it so far randomised 90 adults with obesity for 12 months to an 8-hour eating window, to 25% daily calorie restriction, or to a control group. Total testosterone, DHEA and sex hormone binding globulin did not change over time or between groups in premenopausal or postmenopausal women. Estradiol, estrone and progesterone were measured in the postmenopausal women only and were also unchanged.

An 8-week trial in resistance-trained women found no penalty either. Women eating only between noon and 8pm gained the same fat-free mass, 2% to 3%, as women eating across a 13-hour day, with matched calories and matched protein at 1.6 g per kg per day.

So the strong version of the warning is not supported. Nor is the opposite. A 2026 review of fasting and female reproductive health concluded that direct evidence in women is largely absent, that most protocols are heterogeneous and short, and that caution is warranted in women who are young, lean or already in an energy deficit. Take that last group seriously: the risk in fasting is rarely the clock, it is under-eating.

Menstrual Cycle and Hormonal Considerations

There is very little trial evidence on timing a fasting protocol to the menstrual cycle. Almost none of the published trials report cycle phase at all. If you read a plan that tells you to fast in the follicular phase and eat freely in the luteal phase, that plan is an inference, not a finding.

The one female population with a real signal is polycystic ovary syndrome. Reviews report improvements in hyperandrogenism and menstrual regularity in women with PCOS, plausibly through better insulin sensitivity rather than through the fasting window itself.

What is well established is that a compressed window makes protein and fibre harder to reach. The protein RDA for women aged 19 to 70 is 46 g a day, and the fibre adequate intake is 25 g for women aged 19 to 50 and 21 g from 51. Two meals instead of three does not lower those targets. This is why tracking macros rather than calories alone matters more on a fasting protocol, not less.

Intermittent Fasting for Menopause and Perimenopause

Perimenopause and menopause are a genuinely searched sub-question, and the honest answer is that the dedicated evidence is thin. Most trials enrol adults with overweight or obesity and do not separate perimenopausal from postmenopausal participants in the results.

What can be said:

• In the 12-month hormone trial above, postmenopausal women lost weight on both the 8-hour window and on daily calorie restriction, with no change in estradiol, estrone or progesterone.
• A 2026 narrative review of fasting across the menopausal transition reports favourable metabolic effects in postmenopausal women, and notes those effects are clearest when fasting is combined with physical activity rather than used alone.
• A 2025 review of fasting and weight management at menopause treats it as a promising option, not a proven one.

The practical read: if a shorter eating window helps you hold a deficit through a decade when maintaining muscle is getting harder, it is a reasonable tool. It is not a countermeasure for the metabolic shift itself, and resistance training plus adequate protein has better support for that.

Who Should Not Fast

These are not cautions. They are exclusions.

• Pregnancy. There are no randomised trials of fasting in pregnancy. A 2025 meta-analysis of 19 observational studies covering more than 1.3 million pregnancies found a pooled 94 g reduction in birthweight, with no increase in low birthweight risk. Small, but pregnancy is not a state to experiment on. Read calorie tracking during pregnancy instead.
• Breastfeeding. Human trial evidence is effectively non-existent. The protein RDA during lactation is 71 g a day against 46 g otherwise, and a compressed window works against that.
• Any history of disordered eating. In a survey of 64 people using fasting, EDE-Q scores were higher than community norms across every subscale and 31.25% scored at or above the clinical cut-off. That study is cross-sectional and cannot show which came first, but clinicians have specifically been urged to screen for this before recommending fasting.
• Anyone on glucose-lowering medication. Insulin and sulfonylureas assume you will eat. A systematic review of 68 studies on fasting in type 2 diabetes found hypoglycaemia risk varied sharply by drug class, with sulfonylureas the worst. A trial in insulin-treated type 2 diabetes did report no severe hypoglycaemia on three fasting days a week, but that was with dietary counselling and continuous glucose monitoring in place. Medication doses need adjusting by the prescriber first.

For everyone else, side effects in trials are mild. A pooled analysis of 15 randomised trials in 1,365 adults found no significant difference in fatigue, headache or dropout against controls.

VitaCal Has No Fasting Timer

It is worth stating plainly. VitaCal does not have a fasting timer, a fasting window tracker, or any feature that counts hours since your last meal. There is no cycle-phase-aware calorie target and no menopause mode. If a countdown clock is what you want, this is not the app for it.

What VitaCal does is the part that determines the result. Whatever eating window you choose, the daily total still has to land. Photograph the meal and the AI analysis estimates it, so logging two large meals inside a window takes seconds rather than minutes; accuracy caveats are covered in how accurate AI food recognition really is. Set your daily calorie target and your own protein, carb and fat gram targets, then watch the weekly trend rather than any single day. Two weeks of that will tell you whether your window is producing a deficit or just moving the same calories later.

That feedback loop is the whole reason to track at all, and it is the reason most calorie trackers fail women: they optimise for logging, not for the trend. If you want to see the logging flow first, the photo calorie tracker page walks through it.

Sources

• Semnani-Azad Z, Khan TA, Chiavaroli L, et al. Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials. BMJ. 2025;389:e082007. PMC12175170 (99 trials, 6,582 adults; alternate day fasting 1.29 kg advantage; no advantage in trials of 24 weeks or longer).
• Elortegui Pascual P, Rolands MR, Eldridge AL, et al. A meta-analysis comparing the effectiveness of alternate day fasting, the 5:2 diet, and time-restricted eating for weight loss. Obesity. 2023;31(Suppl 1):9-21. PMC10098946 (24 trials, 1,768 people; 0.26 kg mean difference against continuous energy restriction).
• Lowe DA, Wu N, Rohdin-Bibby L, et al. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial. JAMA Intern Med. 2020;180(11):1491-1499. PMC7522780 (16:8 window, noon to 8pm).
• Liu D, Huang Y, Huang C, et al. Calorie Restriction with or without Time-Restricted Eating in Weight Loss. N Engl J Med. 2022;386(16):1495-1504. MED/35443107 (139 adults, 12 months, 1,200-1,500 kcal for women; 8.0 kg vs 6.3 kg, not significant).
• He H, Qin Z, Liu K, Wang Z, Wang J. The effects of intermittent fasting on BMI, fasting blood glucose, and blood pressure in women with overweight or obesity. Front Nutr. 2026;13:1818813. PMC13218085 (22 trials, 1,287 women; BMI 0.41, fasting glucose 2.18).
• Lin S, Cienfuegos S, Ezpeleta M, et al. Effect of time restricted eating versus daily calorie restriction on sex hormones in males and females with obesity. Eur J Clin Nutr. 2024;78(9):814-817. MED/38866976 (90 adults, 12 months; testosterone, DHEA, SHBG, estradiol, estrone and progesterone unchanged).
• La Vignera S, Condorelli RA. Effects of Intermittent Fasting on Male and Female Reproductive Hormones, Fertility, and Sexual Function. Nutrients. 2026;18:1817. PMC13259202 (evidence gap in women; PCOS signal; caution in young, lean or energy-deficient women).
• Tinsley GM, Moore ML, Graybeal AJ, et al. Time-restricted feeding plus resistance training in active females: a randomized trial. Am J Clin Nutr. 2019;110(3):628-640. PMC6735806 (fat-free mass 2% to 3% in all groups; protein 1.6 g/kg/d).
• Drinnon AR, Calderon A, Dhanasekaran M, Shakil J, Patham B. Sexual Dimorphism and Menopausal Transition: A Narrative Review of the Metabolic and Physical Effects of Intermittent Fasting. Nutrients. 2026;18:1344. PMC13165054 (postmenopausal effects, clearest alongside physical activity).
• Garg R, Chetan R, Jyothi GS, Agrawal P, Gupta P. Intermittent Fasting and Weight Management at Menopause. J Midlife Health. 2025;16(1):14-18. PMC12052274.
• Giorno A, De Simone C, Lopez G, et al. Intermittent Fasting During Pregnancy and Neonatal Birth Weight: A Systematic Review and Meta-Analysis. Nutrients. 2025;17:3546. PMC12655342 (19 observational studies, no trials; 94 g birthweight reduction; low birthweight RR 0.96).
• Cuccolo K, Kramer R, Petros T, Thoennes M. Intermittent fasting implementation and association with eating disorder symptomatology. Eat Disord. 2022;30(5):471-491. MED/34191688 (64 fasters; 31.25% at or above the clinical EDE-Q cut-off).
• Blumberg J, Hahn SL, Bakke J. Intermittent fasting: consider the risks of disordered eating for your patient. Clin Diabetes Endocrinol. 2023;9:4. PMC10589984.
• Abdelrahim D, Faris ME, Hassanein M, et al. Impact of Ramadan Diurnal Intermittent Fasting on Hypoglycemic Events in Patients With Type 2 Diabetes. Front Endocrinol. 2021;12:624423. PMC7984365 (68 studies; sulfonylureas carry the highest hypoglycaemia risk).
• Obermayer A, Tripolt NJ, Pferschy PN, et al. Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2). Diabetes Care. 2023;46(2):463-468. PMC9887629 (three fasting days a week with counselling and continuous glucose monitoring; no severe hypoglycaemia).
• Zhong F, Zhu T, Jin X, et al. Adverse events profile associated with intermittent fasting in adults with overweight or obesity. Nutr J. 2024;23:72. PMC11234547 (15 trials, 1,365 adults; no significant difference in fatigue, headache or dropout).
• National Academies, Dietary Reference Intakes summary tables: macronutrients (protein 46 g for women 19-70 and 71 g in lactation; fibre 25 g at 19-50 and 21 g from 51).

Last checked: 7 September 2026.

Disclaimer: This article is for informational purposes only. Always consult your healthcare provider before starting a fasting protocol, particularly if you are pregnant, breastfeeding, taking any medication, or have a history of disordered eating.